Afuco™ Anti-CD4 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-039)

Customer Review

There are currently no Customer reviews or questions for AFC-TAB-039. Click the button above to contact us or submit your feedback about this product.

Q&As

1. Can antibodies be employed on animals?

   A: Some antibodies can be used for veterinary purposes, however formulations that have been particularly formulated and tested for animal usage are recommended.

2. What's the distinction between cloned and chimeric antibodies?

   A: Humanized antibodies are essentially human, with only the antigen-binding sites coming from a non-human species, whereas chimeric antibodies contain higher amounts of both human and non-human components.

3. Do antibodies necessitate particular removal procedures?

   A: To avoid environmental contamination and maintain safety, follow local legislation and recommendations when disposing of biological products.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Biosimilar Overview

Please refer to Zanolimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Zanolimumab.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Zanolimumab"

Anti-Human CD4 Recombinant Antibody (Zanolimumab)

Recombinant monoclonal antibody to CD4. Zanolimumab (expected trade name HuMax-CD4) is a human monoclonal antibody and an immunosuppressive drug. It is being developed for the treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma.

DrugMonitor™ Anti-Zanolimumab Antibody (VS-1224-YC1341)

Zanolimumab is a fully human monoclonal antibody directed against CD4. The DrugMonitor™ Anti-Zanolimumab Antibody (VS-1224-YC1341) is an anti-drug antibody (ADA) against Zanolimumab. This drug-based antibody is raised in mice immunized with the Zanolimumab. The anti-Zanolimumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Zanolimumab in samples.

See other products for "CD4"

Select a product category from the dropdown menu below to view related products.

Human Antibodies Immunotoxins Fab Antibodies Mouse Antibodies Humanized Antibodies Chimeric Antibodies Fab Glycosylation Antibodies Neutralizing Antibodies Blocking Antibodies Rabbit Monoclonal Antibodies ScFv Antibodies IgG Antibodies ADCC Enhanced Antibodies Antibody Magnetic Beads Hexamer Antibodies NHP Antibodies FC Reagents & Kits ScFv-Fc Chimeras Extracellular Vesicle Antibodies IHC Kits & Antibodies Biparatopic Antibodies